Pfizer starting trial for Omicron-specific Covid-19 vaccine 輝瑞開始奧密克戎疫苗臨床試驗
Pfizer and BioNTech announced they have begun a clinical trial for an Omicron-specific Covid-19 vaccine. CNN’s Dr. Sanjay Gupta reports
Pfizer and BioNTech announced they have begun a clinical trial for an Omicron-specific Covid-19 vaccine. CNN’s Dr. Sanjay Gupta reports
輝瑞BNT研發專攻Omicron疫苗 展開臨床試驗(世界日報)